Kefah Mokbel/LinkedIn
Aug 21, 2025, 11:16
Kefah Mokbel: TAD Proven Safe with Effective Long-Term Outcomes for Breast Cancer Patients
Kefah Mokbel, Chair of Breast Cancer Surgery at London Breast Institute, shared on LinkedIn about a recent paper by Frederikke Munck et al. published on Springer Nature:
“TAD is safe
The low rate of regional nodal recurrence suggests effective long-term regional control and good overall survival for patients receiving TAD without axillary lymph node dissection.”
Title: Oncologic First Events in Breast Cancer Patients After Targeted Axillary Dissection
Authors: Frederikke Munck, Maj-Britt Jensen, Riazan Hawaz-ali and Tove H. F. Tvedskov
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 21, 2025, 11:15
Aug 21, 2025, 10:23
Aug 21, 2025, 10:08
Aug 21, 2025, 09:30
Aug 21, 2025, 08:17
Aug 21, 2025, 06:29
Aug 21, 2025, 00:00